🇺🇸 FDA
Pipeline program

VX-702

VX04-702-301

Phase 2 small_molecule completed

Quick answer

VX-702 for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Rheumatoid Arthritis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials